Lithium Orotate 5mg - 100 capsules

Lithium orotate is a form of lithium, a naturally occurring mineral, that is combined with orotic acid. It is used as a dietary supplement and, unlike other forms of lithium, usually has a lower dose and is believed to cross the blood-brain barrier more easily.

Why is it considered a nootropic? Lithium orotate is considered by some to be a nootropic due to its potential neuroprotective effects and its ability to improve certain cognitive functions and stabilize mood.

Mechanism of action: The exact mechanism of lithium orotate is not fully understood, but lithium is known to have a modulatory effect on neurotransmitters and signals in the brain. It can also influence the brain-derived neurotrophic growth factor (BDNF) signaling pathway, a protein that is essential for the survival, growth and formation of new synapses in neurons.

Benefits of Lithium Orotate

1. Neuroprotection and Prevention of Brain Damage: Lithium orotate has antioxidant properties that protect brain cells from damage due to oxidative stress. In addition, it can protect the brain against various toxins, such as glutamate, which in excess can cause neuronal damage.
2. Mood Stabilization and Antidepressant Properties: Lithium orotate is known for its ability to stabilize highs and lows in people with bipolar disorder. It has also shown potential in the treatment of depression, helping to elevate mood and improve overall well-being.
3. Improved Resilience to Stress: Lithium may improve the brain's ability to adapt and recover from stressful situations, which may be useful for people who face high levels of stress in their daily lives.
4. Promotion of Neurogenesis: Lithium may promote the growth and development of new neurons, especially in the hippocampus, a brain region vital for memory and learning.
5. Improved Memory and Cognitive Functions: It has been suggested that lithium may improve certain cognitive functions, such as short-term memory and concentration, by influencing neurotransmitters and signaling pathways in the brain.
6. Reduction of Aggression and Impulsive Behaviors: There is research that suggests that lithium can act as a behavioral stabilizing agent, reducing aggressive impulses and behaviors.
7. Protection against Alzheimer's Disease: Some studies have proposed that lithium may have a protective role against the development of Alzheimer's disease by inhibiting certain enzymes involved in the formation of plaques in the brain.
8. Circadian Clock Regulation: Lithium may influence our biological clock, helping to regulate sleep and wake patterns and potentially benefiting those with sleep disorders.
9. Anti-inflammatory Effect: There is research suggesting that lithium has anti-inflammatory properties, which could be beneficial in conditions where inflammation plays a role, including certain neurological disorders.
10. Support for Thyroid Health: Lithium may influence thyroid function. Although it may decrease function in some, it has also been used in the treatment of certain thyroid conditions.

It is important to note that although lithium orotate has numerous potential benefits, its effectiveness may vary from person to person. Additionally, many of these benefits are based on preliminary research and more research is needed to fully establish its long-term effectiveness and safety.

Absorption: The combination of lithium with orotic acid in lithium orotate may improve its absorption from the gastrointestinal tract and its passage through the blood-brain barrier compared to other forms of lithium.

Adverse effects and contraindications:

• Adverse effects: Although generally considered safe at low doses, in some people it can cause side effects such as tremor, thirst, frequent urination, bloating with fluid retention, weight gain, and thyroid problems.
• Contraindications: People with kidney or heart diseases, as well as those who are pregnant or breastfeeding, should avoid taking lithium orotate. Additionally, it should not be consumed together with diuretics or non-steroidal anti-inflammatory drugs.
• Drug interactions: Lithium orotate may interact with certain medications, such as antidepressants, antipsychotics, blood pressure medications, among others.

More information about Lithium Orotate and its dosage: https://nootropicsexpert.com/lithium-orotate/

References on studies:

[Yo] Boesgaard AM, Steigman G. (1985). "Big bang nucleosynthesis – Theories and observations". Annual Review of Astronomy and Astrophysics . Palo Alto, CA. 23: 319–378. ( source )

[ii] Swann AC “Norepinephrine and (Na+, K+)-ATPase: evidence for stabilization by lithium or imipramine.” Neuropharmacology . 1988 Mar;27(3):261-7. ( source )

[iii] Herbert V., Colman N. “Release of vitamin binding proteins from granulocytes by lithium: vitamin B12 and folate binding proteins.” Advances in Experimental Medicine and Biology . 1980;127:61-78. ( source )

[iv] Young W. “Review of lithium effects on brain and blood.” Cell Transplantation . 2009;18(9):951-75. ( source )

[v] Schrauzer GN, Shrestha KP “Lithium in drinking water and the incidences of crimes, suicides, and arrests related to drug addictions.” Biological Trace Element Research . 1990 May;25(2):105-13. ( source )

[saw] Ohgami H., Terao T., Shiotsuki I., Ishii N., Iwata N. “Lithium levels in drinking water and risk of suicide.” British Journal of Psychiatry . 2009 May;194(5):464-5 ( source )

[vii] Blüml V., Regier MD, Hlavin G., Rockett IR, König F., Vyssoki B., Bschor T., Kapusta ND “Lithium in the public water supply and suicide mortality in Texas.” Journal of Psychiatric Research. 2013 Mar;47(3):407-11. ( source )

[viii] Terao T., Goto S., Inagaki M., Okamoto Y. “Even very low but sustained lithium intake can prevent suicide in the general population?” Medical Hypotheses . 2009 Nov;73(5):811-2 ( source )

[ix] Cade JFJ “Lithium Salts in the Treatment of Psychotic Excitement” The Medical Journal of Australia Vol. II No. 10, September 3, 1949 ( source )

[x] Wada A. “Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades.” Journal of Pharmacological Sciences . 2009 May;110(1):14-28. ( source )

[xi] Kaidanovich-Beilin O., Milman A., Weizman A., Pick CG, Eldar-Finkelman H. “Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus.” Biological Psychiatry . 2004 Apr 15;55(8):781-4. ( source )

[xii] O'Brien WT, Harper AD, Jové F., Woodgett JR, Maretto S., Piccolo S., Klein PS “Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium.” Journal of Neuroscience . 2004 Jul 28;24(30):6791-8. ( source )

[xiii] Collingridge GL, Watkins JC “The NMDA Receptor.” New York: Oxford Univ. Press; 1994.

[xiv] Chuang D., Christ L., Fujimaki K., Hashimoto R., Jeong MR “Lithium-induced inhibition of Src tyrosine kinase in rat cerebral cortical neurons: A role in neuroprotection against N-methyl-D-aspartate receptor-mediated excitotoxicity” . FEBS Letters 2003; 538(1-3): 45-148 ( source )

[xv] Manji HK, Chen G., Moore GJ “Lithium at 50: Have the neuroprotective effects of this unique cation been overlooked?” Biological Psychiatry 1999; 46(7): 929-940 ( source )

[xvi] Leeds PR, Yu F., Wang Z., Chiu C., Zhang Y., Leng Y., Linares GR, Chuang D. “A New Avenue for Lithium: Intervention in Traumatic Brain Injury” ACS Chemical Neuroscience . 2014 Jun 18; 5(6): 422–433. ( source )

[xvii] Schrauzer GN “Lithium: occurrence, dietary intakes, nutritional essentiality.” Journal of the American College of Nutrition . 2002 Feb;21(1):14-21. ( source )

[xviii] Concha G., Broberg K., Grandér M., Cardozo A., Palm B., Vahter M. “High-level exposure to lithium, boron, cesium, and arsenic via drinking water in the Andes of northern Argentina.” Environmental Science and Technology . 2010 Sep 1;44(17):6875-80 ( source )

[xix] Angelucci F., Aloe L., Jiménez-Vasquez P., Mathé AA “Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression.” International Journal of Neuropsychopharmacology . 2003 Sep;6(3):225-31. ( source )

[xx] Aydin K., Uysal S., Yakut A., Emiroglu B., Yılmaz F. “N-acetylaspartate concentration in corpus callosum is positively correlated with intelligence in adolescents.” Neuroimaging . 2012 Jan 16;59(2):1058-64 ( source )

[xxi] Yucel K., McKinnon MC, Taylor VH, Macdonald K., Alda M., Young LT, MacQueen GM “Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study.” Psychopharmacology (Berlin). 2007 Dec;195(3):357-67 ( source )

[xxii] Schrauzer GN, de Vroey E. “ Effects of nutritional lithium supplementation on mood. “A placebo-controlled study with former drug users.” Biological Trace Element Research . 1994 Jan;40(1):89-101. ( source )

[xxiii] Sartori HE “Lithium orotate in the treatment of alcoholism and related conditions.” Alcohol . 1986 Mar-Apr;3(2):97-100. ( source )

[xxiv] Lakhan S., Vieira KF “Nutritional therapies for mental disorders” Nutrition Journal 2008; 7:2. ( source )